Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	HNF1A ZNF609 L3MBTL2 MBD6 HDAC7 JMJD1C CIC BRD2 NFATC1 GLI2 VAX2 ELK1 ELK4 DMRT1 NOTCH1 CUX1 CRTC2	3.82e-05	739	149	17	GO:0003682
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HNF1A FOXK2 MEF2D CASZ1 KMT2D NFATC1 GLI2 PLAGL1 PLAGL2 ELK1 ELK4 ONECUT3 DMRT1 NOTCH1	8.01e-05	560	149	14	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HNF1A FOXK2 MEF2D CASZ1 KMT2D NFATC1 GLI2 PLAGL1 PLAGL2 ELK1 ELK4 ONECUT3 DMRT1 NOTCH1	8.97e-05	566	149	14	GO:0001216
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	HNF1A TGIF2 FOXK2 ZNF621 ZNF280B HIF3A LHX8 CIC MEF2D CASZ1 OLIG3 KMT2D NFATC1 GLI2 SPDEF PLAGL1 PLAGL2 VAX2 ELK1 ELK4 ONECUT3 DMRT1 NOTCH1 CUX1	1.24e-04	1412	149	24	GO:0000981
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	HNF1A TGIF2 FOXK2 ZNF621 ZNF280B HIF3A MEF2D BPTF OLIG3 NFATC1 GLI2 NLRC5 PLAGL1 VAX2 ELK1 ELK4 SNAPC4 ONECUT3 DMRT1 NOTCH1 CUX1	4.98e-04	1271	149	21	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	HNF1A TGIF2 FOXK2 ZNF621 ZNF280B HIF3A LHX8 CIC MEF2D CASZ1 BPTF OLIG3 NFATC1 GLI2 NLRC5 PLAGL1 VAX2 ELK1 ELK4 SNAPC4 ONECUT3 DMRT1 CUX1	5.09e-04	1459	149	23	GO:0000977
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	HNF1A ZNF609 FOXK2 NACA HIF3A MEF2D CASZ1 GSK3A MAP3K1 BPTF OLIG3 KMT2D NFATC1 GLI2 FHOD1 NLRC5 SPDEF PLAGL1 PLAGL2 ELK1 ELK4 ONECUT3 DMRT1 NOTCH1 MRTFA CRTC2	6.84e-06	1390	149	26	GO:0045944
GeneOntologyBiologicalProcess	neuron development	SLC4A7 PLEKHG4 UNC5B HCN1 NTNG1 CUL7 LHX8 ARHGEF25 WNK1 GSK3A KIAA0319 OLIG3 NEO1 GLI2 DOCK7 IQSEC1 UNK VAX2 SEMA6A FLRT1 ALK SLC9A6 NOTCH1 CUX1 MRTFA OTOG	1.68e-05	1463	149	26	GO:0048666
GeneOntologyCellularComponent	chromatin	HNF1A TGIF2 FOXK2 GATAD2A HIF3A LHX8 SRCAP JMJD1C CIC MEF2D CASZ1 BPTF FANCF OLIG3 BRD2 NFATC1 SPDEF VAX2 ELK1 ELK4 ONECUT3 DMRT1 UHRF2 CUX1	1.13e-04	1480	148	24	GO:0000785
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZXDC FOXK2 EPPK1 TMCO6 SFI1 FBXL19 WRAP53 SRCAP MBD6 MAST2 WNK1 HDAC7 CIC CASZ1 TBC1D9 THADA ZC3H11A KMT2D SYNE3 BRD2 NFATC1 NLRC5 SNAPC4 BCL2L13 ARHGAP21 NOTCH1 WNK2	5.26e-13	1105	154	27	35748872
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZXDC HNF1A TGIF2 ZNF609 ZNF280B FBXL19 LHX8 SRCAP CIC MEF2D ZC3H10 BPTF BRD2 NFATC1 UNK SPDEF PLAGL2 ELK1 SNAPC4 DMRT1 UHRF2 CUX1 MRTFA	1.55e-12	808	154	23	20412781
Pubmed	A census of human transcription factors: function, expression and evolution.	HNF1A FOXK2 HIF3A LHX8 CIC MEF2D OLIG3 ZC3H11A KMT2D NFATC1 GLI2 SPDEF PLAGL1 PLAGL2 VAX2 ELK1 ELK4 SNAPC4 ONECUT3 DMRT1	4.17e-09	908	154	20	19274049
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF609 L3MBTL2 ATG2B USP24 RBBP8NL JMJD1C CIC KMT2D ANAPC1 ATF7IP DOCK7 ARHGAP21 CUX1 MRTFA	6.05e-09	418	154	14	34709266
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	USP24 WRAP53 HDAC7 CIC MEF2D GSK3A TBC1D9 BPTF ZC3H11A KMT2D BRD2 ANAPC1 FHOD1 IQSEC1 OTUD4 UNK SNAPC4 MRTFA	1.16e-08	774	154	18	15302935
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ZNF609 EPPK1 WNK1 CIC MAP3K1 GLI2 RNF38 UNK BSN NOTCH1 WNK2 MRTFA CRTC2	7.12e-08	430	154	13	35044719
Pubmed	Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.	MAST2 MAST1 NOTCH1	8.51e-08	3	154	3	22101766
Pubmed	Human transcription factor protein interaction networks.	HNF1A ZNF609 FOXK2 GATAD2A L3MBTL2 NACA CUL7 LHX8 SRCAP MBD6 JMJD1C CIC MEF2D BPTF KMT2D BRD2 GLI2 ATF7IP OTUD4 UNK ELK4 CUX1 SEC23B	8.90e-08	1429	154	23	35140242
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZXDC HNF1A TGIF2 FOXK2 HIF3A LHX8 CIC MEF2D OLIG3 BRD2 GLI2 SPDEF PLAGL2 ELK4 UHRF2 CUX1	1.19e-07	709	154	16	22988430
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 FOXK2 ANKMY1 SYNPO RBBP8NL JMJD1C CASZ1 BPTF THADA ZC3H11A INTS2 NFATC1 TBC1D22A GLI2 NUP210 NLRC5 MAST1 SEMA6A ELK4 CLEC16A CUX1 ADGRD1 WNK2	1.85e-07	1489	154	23	28611215
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXK2 SLC4A7 GATAD2A L3MBTL2 PLEKHG4 CUL7 JMJD1C CIC MEF2D CASZ1 BPTF ZC3H11A KMT2D NFATC1 ANAPC1 NOTCH1 CUX1	2.89e-07	857	154	17	25609649
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CUL7 MAST2 WNK1 HDAC7 ANAPC1 TBC1D22A AMOTL1 DOCK7 UNK CEP295 NOTCH1 CRTC2	7.92e-07	446	154	12	24255178
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	TGIF2 LHX8 MEF2D OLIG3 NFATC1 GLI2 SPDEF VAX2 ELK1 ELK4 ONECUT3 DMRT1 CUX1	1.02e-06	544	154	13	28473536
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZNF609 FOXK2 GATAD2A NACA CIC MEF2D BPTF GRHPR FHOD1 ARHGAP21 CUX1 MRTFA	1.43e-06	472	154	12	38943005
Pubmed	Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae.	ELK1 ELK4 MRTFA	1.69e-06	6	154	3	23563308
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	FOXK2 GATAD2A L3MBTL2 SYNPO SRCAP JMJD1C CIC CASZ1 BPTF BRD2 SNAPC4 UHRF2 CUX1	3.46e-06	608	154	13	36089195
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	ZNF609 GATAD2A JMJD1C BPTF	5.99e-06	27	154	4	23395962
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZCCHC2 THADA DOCK7 UNK CEP295 WNK2	6.48e-06	102	154	6	11214970
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZNF609 SRCAP WNK1 CIC KIAA0319 CLEC16A	7.25e-06	104	154	6	9205841
Pubmed	Common genetic variants associated with breast cancer and mammographic density measures that predict disease.	SLC4A7 HCN1 MAP3K1	9.99e-06	10	154	3	20145138
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	DNAH2 MEF2D CASZ1 IQSEC1 MAST1 CEP295 BSN WNK2	1.01e-05	233	154	8	37704626
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZNF609 FOXK2 GATAD2A JMJD1C CASZ1 KMT2D BRD2 ATF7IP ELK1 CUX1	1.22e-05	398	154	10	35016035
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CUL7 ZCCHC2 SRCAP WNK1 CIC GSK3A ALDH1A2 NFATC1 ANAPC1 ATF7IP UNK BSN	1.32e-05	588	154	12	38580884
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RNPC3 NTNG1 CUL7 ZCCHC2 WNK1 JMJD1C CASZ1 TBC1D9 THADA NUP210 UNC80	1.35e-05	493	154	11	15368895
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	ZXDC FOXK2 GATAD2A L3MBTL2 CUL7 FBXL19 MBD6 BPTF KMT2D BRD2 ANAPC1	1.40e-05	495	154	11	27705803
Pubmed	Integration of MAP kinase signal transduction pathways at the serum response element.	MAP3K1 ELK1	1.95e-05	2	154	2	7618106
Pubmed	Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts.	NFATC1 NOTCH1	1.95e-05	2	154	2	21131365
Pubmed	Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5.	FER1L4 NLRC5	1.95e-05	2	154	2	31694750
Pubmed	ERK Signaling Controls Innate-like CD8+ T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors.	ELK1 ELK4	1.95e-05	2	154	2	30068599
Pubmed	WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia.	WNK1 WNK2	1.95e-05	2	154	2	35849656
Pubmed	Thyroid hormone regulates protease expression and activation of Notch signaling in implantation and embryo development.	PRSS29P NOTCH1	1.95e-05	2	154	2	28993437
Pubmed	WNK signaling is involved in neural development via Lhx8/Awh expression.	LHX8 WNK1	1.95e-05	2	154	2	23383144
Pubmed	MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions.	MAST2 NOTCH1	1.95e-05	2	154	2	24140425
Pubmed	[Correlation of netrin-1 expression with invasion of extra villous trophoblasts].	UNC5B NEO1	1.95e-05	2	154	2	19570425
Pubmed	Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	PLAGL1 PLAGL2	1.95e-05	2	154	2	36437415
Pubmed	Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.	TANK MAP3K1	1.95e-05	2	154	2	23634849
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	OMA1 UNC5B NTNG1 NEO1 SEMA6A CUX1	2.17e-05	126	154	6	16284245
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF609 SLC4A7 TANK L3MBTL2 NACA WNK1 JMJD1C NEO1 ANAPC1 TBC1D22A AMOTL1 UNK CEP295	2.51e-05	733	154	13	34672954
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RABEP2 PRR36 HCN1 SYNPO KIAA0319 ANAPC1 ATF7IP DOCK7 IQSEC1 OTUD4 BSN UNC79 ARHGAP21 CUX1 WNK2	2.66e-05	963	154	15	28671696
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZNF609 JMJD1C CIC MEF2D CASZ1 KMT2D INTS4 CUX1	2.77e-05	268	154	8	33640491
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TNK1 SLC4A7 MAST2 WNK1 HDAC7 CIC MEF2D GSK3A DOCK7 IQSEC1 ARHGAP21 SEC23B CRTC2 OTOG	3.14e-05	861	154	14	36931259
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	JMJD1C CIC BPTF KMT2D CUX1	3.51e-05	83	154	5	28794006
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATG2B USP24 SRCAP JMJD1C BPTF ZC3H11A KMT2D ANAPC1 AMOTL1 DOCK7 CUX1	3.62e-05	549	154	11	38280479
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	ZNF609 FOXK2 GATAD2A USP24 CUL7 INTS2 ANAPC1 CUX1	3.97e-05	282	154	8	23667531
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SLC4A7 MUC16 THADA NEO1 ZC3H11A LIPE ATF7IP AMOTL1 DOCK7 CLEC16A ARHGAP21 CUX1 SEC23B	4.56e-05	777	154	13	35844135
Pubmed	Discovery and refinement of loci associated with lipid levels.	HNF1A JMJD1C MAP3K1 GPR146 FER1L4 DOCK7 STARD3	4.57e-05	211	154	7	24097068
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	HNF1A JMJD1C MAP3K1 FER1L4 DOCK7 STARD3	4.98e-05	146	154	6	20686565
Pubmed	A multipotent progenitor domain guides pancreatic organogenesis.	TGIF2 HIF3A MEF2D BRD2 SPDEF	5.46e-05	91	154	5	17609113
Pubmed	Transcription factors expressed in olfactory bulb local progenitor cells revealed by genome-wide transcriptome profiling.	GLI2 ATF7IP PLAGL1 PLAGL2 NOTCH1	5.46e-05	91	154	5	21194568
Pubmed	Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinae.	ELK1 ELK4	5.83e-05	3	154	2	25203538
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 SPDEF	5.83e-05	3	154	2	33232357
Pubmed	Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy.	UNC79 UNC80	5.83e-05	3	154	2	26708753
Pubmed	Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).	UNC79 UNC80	5.83e-05	3	154	2	30167850
Pubmed	Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.	KMT2D NOTCH1	5.83e-05	3	154	2	27566587
Pubmed	Adhesion regulates MAP kinase/ternary complex factor exchange to control a proliferative transcriptional switch.	ELK1 ELK4	5.83e-05	3	154	2	23063436
Pubmed	Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.	HCN1 MAP3K1	5.83e-05	3	154	2	28178648
Pubmed	Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.	ELK1 ELK4	5.83e-05	3	154	2	9644975
Pubmed	Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development.	ELK1 ELK4	5.83e-05	3	154	2	20554967
Pubmed	Wnk kinases are positive regulators of canonical Wnt/β-catenin signalling.	WNK1 WNK2	5.83e-05	3	154	2	23797875
Pubmed	Hepatic Expression of NTN4 and Its Receptors in Patients with Hepatocellular Carcinoma.	UNC5B NEO1	5.83e-05	3	154	2	38156865
Pubmed	Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.	UNC79 UNC80	5.83e-05	3	154	2	21040849
Pubmed	Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex.	UNC79 UNC80	5.83e-05	3	154	2	32620897
Pubmed	Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B.	UNC5B NEO1	5.83e-05	3	154	2	18719102
Pubmed	Net, a new ets transcription factor that is activated by Ras.	ELK1 ELK4	5.83e-05	3	154	2	7958835
Pubmed	Transcriptional activation capacity of the novel PLAG family of zinc finger proteins.	PLAGL1 PLAGL2	5.83e-05	3	154	2	9722527
Pubmed	Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4.	ELK1 ELK4	5.83e-05	3	154	2	28275114
Pubmed	WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.	WNK1 NFATC1	5.83e-05	3	154	2	31022353
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	GATAD2A SRCAP MBD6 HDAC7 BPTF KMT2D	7.45e-05	157	154	6	30186101
Pubmed	Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations.	MAST2 MAST1 CUX1	7.83e-05	19	154	3	30449657
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	UNC5B NTNG1 SEMA6A FLRT1	8.48e-05	52	154	4	26633812
Pubmed	Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP.	SRCAP NOTCH1	1.16e-04	4	154	2	21673954
Pubmed	Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control.	ALDH1A2 NOTCH1	1.16e-04	4	154	2	24331925
Pubmed	Locations of the ets subfamily members net, elk1, and sap1 (ELK3, ELK1, and ELK4) on three homologous regions of the mouse and human genomes.	ELK1 ELK4	1.16e-04	4	154	2	8575773
Pubmed	WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.	WNK1 WNK2	1.16e-04	4	154	2	11571656
Pubmed	Human hypertension caused by mutations in WNK kinases.	WNK1 WNK2	1.16e-04	4	154	2	11498583
Pubmed	Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.	MAST2 MAST1	1.16e-04	4	154	2	15951562
Pubmed	Regulation of cardiomyocyte Glut4 expression by ZAC1.	MEF2D PLAGL1	1.16e-04	4	154	2	20363751
Pubmed	Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta.	GSK3A NOTCH1	1.16e-04	4	154	2	19214430
Pubmed	The ETS-domain transcription factor family.	ELK1 ELK4	1.16e-04	4	154	2	9570133
Pubmed	MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages.	ELK4 MRTFA	1.16e-04	4	154	2	24758171
Pubmed	Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators.	ELK1 ELK4	1.16e-04	4	154	2	31461342
Pubmed	Notch suppresses nuclear factor of activated T cells (NFAT) transactivation and Nfatc1 expression in chondrocytes.	NFATC1 NOTCH1	1.16e-04	4	154	2	23264614
Pubmed	Axon morphogenesis and maintenance require an evolutionary conserved safeguard function of Wnk kinases antagonizing Sarm and Axed.	WNK1 WNK2	1.16e-04	4	154	2	34384519
Pubmed	Diet change and exercise enhance protein expression of CREB, CRTC 2 and lipolitic enzymes in adipocytes of obese mice.	LIPE CRTC2	1.16e-04	4	154	2	27596982
Pubmed	Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.	MEF2D NFATC1	1.16e-04	4	154	2	17111365
Pubmed	Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases.	MAST2 MAST1	1.16e-04	4	154	2	10404183
Pubmed	The NALCN channel complex is voltage sensitive and directly modulated by extracellular calcium.	UNC79 UNC80	1.16e-04	4	154	2	32494638
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	L3MBTL2 USP24 WRAP53 MAST2 JMJD1C GSK3A MAP3K1 BRD2 INTS2 TBC1D22A GYS2 AMOTL1 UNK ELK4 SNAPC4 ADGRD1	1.34e-04	1242	154	16	30973865
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	GATAD2A NTNG1 SEMA6A FLRT1 ALK NOTCH1 CUX1	1.35e-04	251	154	7	29031500
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	GATAD2A USP24 DNAH2 MUC16 CIC CASZ1 KMT2D OTUD4 CEP295 BSN CUX1	1.37e-04	638	154	11	31182584
Pubmed	Draxin from neocortical neurons controls the guidance of thalamocortical projections into the neocortex.	UNC5B NTNG1 NEO1	1.41e-04	23	154	3	26659141
Pubmed	Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons.	UNC5B NTNG1 NEO1	1.61e-04	24	154	3	26633881
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	L3MBTL2 JMJD1C MEF2D BRD2 NFATC1 NOTCH1	1.72e-04	183	154	6	36129980
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TANK JMJD1C MEF2D ZC3H11A KMT2D NOTCH1	1.78e-04	184	154	6	32908313
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	TGIF2 FOXK2 LHX8 CIC SPDEF ELK1 ELK4	1.80e-04	263	154	7	20932939
Pubmed	Netrin 1 acts as an attractive or as a repulsive cue for distinct migrating neurons during the development of the cerebellar system.	UNC5B NEO1	1.93e-04	5	154	2	10704383
Pubmed	Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.	HCN1 MAP3K1	1.93e-04	5	154	2	19232126
Pubmed	Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase.	ELK1 ELK4	1.93e-04	5	154	2	9020136
Pubmed	p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation.	MEF2D KMT2D	1.93e-04	5	154	2	18026121
Pubmed	The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.	ELK1 ELK4	1.93e-04	5	154	2	20304071
Interaction	KLF3 interactions	ZNF609 FOXK2 GATAD2A L3MBTL2 LHX8 MBD6 JMJD1C CIC MEF2D BPTF KMT2D ATF7IP	1.55e-07	228	151	12	int:KLF3
Interaction	HDAC1 interactions	RABEP2 TGIF2 ZNF609 FOXK2 GATAD2A L3MBTL2 ATG2B USP24 HDAC7 JMJD1C CIC MEF2D CASZ1 GSK3A BPTF KMT2D NFATC1 GLI2 DOCK7 PLAGL1 ELK1 UHRF2 ARHGAP21 NOTCH1 CUX1 MRTFA	2.00e-07	1108	151	26	int:HDAC1
Interaction	TOP3B interactions	ZXDC FOXK2 EPPK1 TMCO6 SFI1 FBXL19 WRAP53 SRCAP MBD6 MAST2 WNK1 HDAC7 CIC CASZ1 TBC1D9 THADA ZC3H11A KMT2D SYNE3 BRD2 NFATC1 OTUD4 NLRC5 UNK SNAPC4 BCL2L13 ARHGAP21 NOTCH1 SEC23B WNK2	4.10e-07	1470	151	30	int:TOP3B
Interaction	HNF1B interactions	HNF1A ZNF609 FOXK2 MBD6 CIC MEF2D BPTF KMT2D ATF7IP CUX1	1.74e-06	190	151	10	int:HNF1B
Interaction	HNF4A interactions	HNF1A ZNF609 FOXK2 L3MBTL2 SRCAP CIC BPTF KMT2D BRD2 ATF7IP CUX1	7.43e-06	275	151	11	int:HNF4A
Interaction	SMARCA5 interactions	HNF1A FOXK2 GATAD2A L3MBTL2 CUL7 CIC GSK3A BPTF BRD2 NFATC1 UHRF2 CLEC16A NOTCH1	1.52e-05	415	151	13	int:SMARCA5
Interaction	RCOR1 interactions	FOXK2 GATAD2A L3MBTL2 ATG2B USP24 JMJD1C CIC KMT2D ANAPC1 DOCK7 UHRF2 ARHGAP21 CUX1 MRTFA	2.17e-05	494	151	14	int:RCOR1
Interaction	C19orf38 interactions	OMA1 USP24 TBC1D9 THADA INTS2 INTS4	4.60e-05	86	151	6	int:C19orf38
Interaction	FOXK2 interactions	RABEP2 FOXK2 MBD6 CIC MEF2D BPTF KMT2D NFATC1 CUX1	5.14e-05	225	151	9	int:FOXK2
Interaction	NFIX interactions	ZNF609 FOXK2 L3MBTL2 SRCAP CIC BPTF KMT2D BRD2 CUX1	5.51e-05	227	151	9	int:NFIX
GeneFamily	Zinc fingers CCCH-type	ZC3H11B ZC3H10 ZC3H11A UNK	5.87e-05	35	110	4	73
GeneFamily	CD molecules\|Mucins	MUC3B MUC15 MUC16	2.69e-04	21	110	3	648
GeneFamily	ETS transcription factor family	SPDEF ELK1 ELK4	6.43e-04	28	110	3	534
GeneFamily	CUT class homeoboxes and pseudogenes	ONECUT3 CUX1	1.28e-03	9	110	2	527
GeneFamily	PHD finger proteins	FBXL19 BPTF KMT2D UHRF2	2.22e-03	90	110	4	88
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR21 UNC5B FBXL19 TBC1D9 THADA IQSEC1 VWA3B	2.07e-06	170	153	7	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 SFI1 PIEZO2 ONECUT3 UNC79 UNC80 OTOG	3.50e-06	184	153	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 SFI1 PIEZO2 ONECUT3 UNC79 UNC80 OTOG	3.50e-06	184	153	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 SFI1 PIEZO2 ONECUT3 UNC79 UNC80 OTOG	3.50e-06	184	153	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Skin-nan-24m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR LHX8 PIGZ FNDC1 VAX2 ADGRD1 SLC44A3	3.62e-06	185	153	7	8433a337625ff8398520e223ef92bf9bb0beb14c
ToppCell	facs-Skin-nan-24m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR LHX8 PIGZ FNDC1 VAX2 ADGRD1 SLC44A3	3.62e-06	185	153	7	049d793d043d5d434f143025de49dd210d18756c
ToppCell	facs-Skin-nan-24m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR LHX8 PIGZ FNDC1 VAX2 ADGRD1 SLC44A3	3.62e-06	185	153	7	63200c42565eea596f9b00728e70e544b8d50a7f
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ISLR ARHGEF25 PIGZ FNDC1 NEO1 GLI2 ADGRD1	4.95e-06	194	153	7	ca1f24070424b44b7a442e4fca761ebfbe24b063
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLC4A7 RNPC3 USP24 SFI1 BPTF ATF7IP NLRC5	5.85e-06	199	153	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 CASZ1 GLI2 SPDEF FUT6 WNK2 SLC44A3	6.05e-06	200	153	7	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	STAB2 MUC15 UNC5B PCDHB12 PIEZO2 SLC44A3	2.14e-05	163	153	6	961c3a1303108afd680365466045f3460a30a7b0
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4\|TCGA-Liver / Sample_Type by Project: Shred V9	TGIF2 EPPK1 SFI1 PIGZ PLAGL2 WNK2	2.63e-05	169	153	6	0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	HDAC7 CASZ1 PIEZO2 SEMA6A BCL2L13 NOTCH1	3.09e-05	174	153	6	b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	HCN1 ASPHD2 F5 PIEZO2 UNC79 UNC80	3.20e-05	175	153	6	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	HCN1 ASPHD2 F5 PIEZO2 UNC79 UNC80	3.20e-05	175	153	6	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRR36 HCN1 AOX1 F5 ONECUT3 BSN	3.30e-05	176	153	6	2e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ABCA3 DNAH2 ASPHD2 ZCCHC2 NFATC1 ONECUT3	3.30e-05	176	153	6	1870860a9ebe7a655c4ea8898427e1097ee23113
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	STAB2 HDAC7 PIEZO2 PRCP NUP210 SEMA6A	3.63e-05	179	153	6	d24513a404c9b1d37dd47aa1cdb5713b64b88f89
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF609 HCN1 NTNG1 TBC1D9 UNC79 UNC80	3.74e-05	180	153	6	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 USP24 WNK1 CASZ1 TBC1D9 OPTC	3.86e-05	181	153	6	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 NTNG1 KIAA0319 FLRT1 UNC80 SLC44A3	4.23e-05	184	153	6	6388c47b7f1d8203e3069eba0e74107256dcae51
ToppCell	droplet-Heart-4Chambers-18m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 NTNG1 KIAA0319 FLRT1 UNC80 SLC44A3	4.23e-05	184	153	6	d83ae1dc64aa1b27d3b524c137567418cc0ff8c6
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FBXL19 TBC1D9 KIAA0319 MAST1 BSN UNC79	4.49e-05	186	153	6	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	UNC5B HCN1 NTNG1 ISLR ALDH1A2 ZNF804B	4.49e-05	186	153	6	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 UNC5B HIF3A PIEZO2 SYNE3 SEMA6A	5.05e-05	190	153	6	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AOX1 ALDH1A2 PIEZO2 GLI2 VAX2 ADGRD1	5.05e-05	190	153	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 UNC5B HIF3A PIEZO2 SYNE3 SEMA6A	5.05e-05	190	153	6	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 UNC5B HIF3A PIEZO2 SYNE3 SEMA6A	5.05e-05	190	153	6	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	STAB2 CASZ1 PIEZO2 PRCP NUP210 SEMA6A	5.20e-05	191	153	6	44c596984c6196f6014e0e405dbe5560841e54ff
ToppCell	E16.5-samps-Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	STAB2 CASZ1 PIEZO2 PRCP NUP210 SEMA6A	5.20e-05	191	153	6	e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 HDAC7 GSK3A MAP3K1 ATF7IP CUX1	5.67e-05	194	153	6	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	droplet-Lung-nan-21m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NTNG1 ISLR ARHGEF25 PIGZ FNDC1 GLI2	5.67e-05	194	153	6	95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NTNG1 ISLR ARHGEF25 PIGZ FNDC1 GLI2	5.67e-05	194	153	6	2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 HDAC7 GSK3A MAP3K1 ATF7IP CUX1	5.67e-05	194	153	6	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NACA HIF3A ALDH1A2 PIEZO2 GLI2 PLAGL1	5.67e-05	194	153	6	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	21-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	AOX1 PCDHB12 NTNG1 ISLR ALDH1A2 PIEZO2	5.67e-05	194	153	6	749dd8113ef260e00facac09de9861d61725124a
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 HDAC7 GSK3A MAP3K1 ATF7IP CUX1	5.67e-05	194	153	6	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARPP21 MUC16 WRAP53 UNC79 UNC80 WNK2	5.67e-05	194	153	6	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARPP21 AOX1 MUC16 PLAC4 F5 UNC80	5.84e-05	195	153	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARPP21 AOX1 MUC16 PLAC4 F5 UNC80	5.84e-05	195	153	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 SPDEF BSN FUT6 WNK2 SLC44A3	5.84e-05	195	153	6	fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 ISLR FNDC1 NEO1 DOCK7 ADGRD1	6.01e-05	196	153	6	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STAB2 LINC00528 HDAC7 TBC1D9 NFATC1 PRCP	6.01e-05	196	153	6	629236f95c838a473b5964a49b7c1b7ad863ea12
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	WNK1 TBC1D9 ZC3H11A BRD2 PRCP NUP210	6.01e-05	196	153	6	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KCNK9 ATF7IP NLRC5 ONECUT3 SLC44A3	6.16e-05	121	153	5	19333a660800b583fa27b495c1f7828e6636a257
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARPP21 HCN1 F5 UNC79 UNC80 WNK2	6.35e-05	198	153	6	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARPP21 UNC5B MUC16 CUL7 WRAP53 WNK2	6.35e-05	198	153	6	dd0465b45b02cb8edf0914d19afb52fcaaeb012c
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	STAB2 HIF3A GPR146 ALDH1A2 PIEZO2 SEMA6A	6.35e-05	198	153	6	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	STAB2 HIF3A GPR146 ALDH1A2 PIEZO2 SEMA6A	6.35e-05	198	153	6	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARPP21 HCN1 F5 UNC79 UNC80 WNK2	6.35e-05	198	153	6	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	TNFRSF25 EPPK1 ZCCHC2 WNK1 BTN3A3 NLRC5	6.35e-05	198	153	6	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	STAB2 UNC5B HIF3A NFATC1 SEMA6A UHRF2	6.53e-05	199	153	6	88f33b8dcd837abfa1d12c28719e073a7da6e979
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STAB2 UNC5B HIF3A NFATC1 SEMA6A UHRF2	6.53e-05	199	153	6	64b19aff72e2a109cb5857cb248bd4712dd49b43
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STAB2 UNC5B HIF3A NFATC1 SEMA6A UHRF2	6.53e-05	199	153	6	2b9e1e069b36b3a61cc3e384f4523687b0e03905
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 CASZ1 GLI2 SPDEF FUT6 WNK2	6.71e-05	200	153	6	ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 CASZ1 GLI2 SPDEF FUT6 WNK2	6.71e-05	200	153	6	85c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	PLEKHG4 LHX8 MBD6 HDAC7 UNK	7.47e-05	126	153	5	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-5\|TCGA-Endometrium / Sample_Type by Project: Shred V9	HIF3A CIC OPTC PLAGL2 FLRT1	8.05e-05	128	153	5	5c2e492bc586d0b20a9516022aa363992675e657
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	RABEP2 RNPC3 ASPHD2 FNDC1 AMOTL1	1.15e-04	138	153	5	8d70e64843f7c3be8ee4203cc126fdf1001f0df5
ToppCell	Control-B_intermediate-6\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PCDHB7 SYNPO TBC1D9 IQSEC1 NLRC5	1.59e-04	148	153	5	662c057030effc9eb61216e81d3967e6983c244f
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	ZXDC TNFRSF25 SYNPO SFI1 CUL7 WNK1 MEF2D CASZ1 GSK3A NUP210 FUT6	7.48e-08	193	152	11	4322_UP
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	RABEP2 ABCA3 EPPK1 CUL7 MAST2 HDAC7 TBC1D22A NUP210 OTUD4 CLEC16A MRTFA	9.70e-08	198	152	11	6742_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	RABEP2 TGIF2 EPPK1 ATG2B SYNPO SRCAP HDAC7 THADA PLAGL2 SNAPC4	9.06e-07	198	152	10	2069_DN
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A	TNFRSF25 SLC4A7 ANKMY1 SFI1 MAST2 HDAC7 MEF2D ELK1 CUX1	5.94e-06	192	152	9	1562_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TNFRSF25 UNC5B SFI1 CUL7 PIGZ CIC CASZ1 PLAGL1 VAX2	6.20e-06	193	152	9	2209_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A	RABEP2 CUL7 CASZ1 GSK3A NUP210 PLAGL1 PLAGL2 ELK1 FUT6	6.46e-06	194	152	9	1377_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A	RABEP2 TNFRSF25 SLC4A7 AOX1 SRCAP MAST2 GSK3A MAP3K1 ELK4	6.74e-06	195	152	9	4402_DN
Drug	PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A	RABEP2 EPPK1 TMCO6 SRCAP WNK1 PIGZ HDAC7 ELK4 SNAPC4	6.74e-06	195	152	9	7072_UP
Drug	Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; PC3; HT_HG-U133A	TNK1 TNFRSF25 SYNPO TBC1D9 HROB NUP210 SPDEF SNAPC4 NOTCH1	7.02e-06	196	152	9	6627_DN
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A	RABEP2 TANK PRR36 CIC FHOD1 NUP210 PLAGL1 ELK1 MRTFA	7.02e-06	196	152	9	1679_DN
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A	RABEP2 TNFRSF25 STAB2 SFI1 MAP3K1 ALDH1A2 FUT6 ALK MRTFA	7.02e-06	196	152	9	6633_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 SLC4A7 AOX1 ANKMY1 MAST2 HDAC7 TBC1D22A MRTFA	7.02e-06	196	152	9	4359_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 EPPK1 GATAD2A PRR36 SFI1 CUL7 WNK1 FHOD1	7.02e-06	196	152	9	5232_UP
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A	TNFRSF25 TGIF2 FOXK2 SLC4A7 UNC5B SFI1 MAST2 CIC GSK3A	7.32e-06	197	152	9	1746_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	SLC4A7 SRCAP WNK1 HDAC7 GSK3A TBC1D9 NUP210 SNAPC4 FUT6	7.32e-06	197	152	9	1803_DN
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 PRR36 ATG2B ANKMY1 HDAC7 MAP3K1 HROB VAX2	7.94e-06	199	152	9	7496_UP
Drug	Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; HL60; HG-U133A	TGIF2 TMCO6 CIC CASZ1 GSK3A TBC1D22A PLAGL2 FUT6 SEC23B	7.94e-06	199	152	9	1719_DN
Drug	Mifepristone [84371-65-3]; Up 200; 9.4uM; HL60; HG-U133A	FOXK2 SLC4A7 ANKMY1 GSK3A FANCF THADA TBC1D22A PLAGL2 SEC23B	7.94e-06	199	152	9	1569_UP
Drug	Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; HL60; HG-U133A	TNFRSF25 TGIF2 UNC5B NACA CUL7 ZCCHC2 MAST2 THADA SNAPC4	7.94e-06	199	152	9	1727_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	EPPK1 PRR36 MAST2 HDAC7 CIC HROB FHOD1 IQSEC1 NOTCH1	8.27e-06	200	152	9	3322_UP
Drug	Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A	TNFRSF25 SFI1 SRCAP GSK3A ALDH1A2 ELK1 SNAPC4 FUT6	4.12e-05	189	152	8	5675_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ZNF609 PRR36 ANKMY1 CUL7 SRCAP HROB TBC1D22A ELK1	4.77e-05	193	152	8	3973_DN
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	STAB2 MAST2 F5 GSK3A HROB IQSEC1 SPDEF VAX2	4.95e-05	194	152	8	6195_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A	ZNF609 UNC5B HDAC7 NFATC1 TBC1D22A FHOD1 ELK1 FLRT1	4.95e-05	194	152	8	3015_DN
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A	RABEP2 SFI1 HIF3A CUL7 WNK1 KMT2D LIPE SEMA6A	4.95e-05	194	152	8	6457_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	EPPK1 PRR36 UNC5B SRCAP F5 CIC HROB MRTFA	4.95e-05	194	152	8	3969_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	TNFRSF25 ZNF609 FOXK2 MAST2 HDAC7 FHOD1 IQSEC1 NOTCH1	4.95e-05	194	152	8	4524_DN
Drug	Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A	ZNF609 SFI1 HDAC7 BTN3A3 BSN FUT6 DMRT1 TRIM38	4.95e-05	194	152	8	3556_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A	ZNF609 FOXK2 ZCCHC2 MAST2 BPTF FANCF THADA SNAPC4	4.95e-05	194	152	8	2009_DN
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A	ZNF609 PRR36 SFI1 SRCAP CIC MAP3K1 HROB NUP210	5.13e-05	195	152	8	4147_DN
Drug	5-aminosalicylic acid; Up 200; 100uM; MCF7; HG-U133A	TNFRSF25 ZNF609 TMCO6 SFI1 PIGZ GSK3A FUT6 TRIM38	5.13e-05	195	152	8	124_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZXDC EPPK1 TMCO6 BPTF FHOD1 IQSEC1 ELK1 ELK4	5.13e-05	195	152	8	6973_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	RABEP2 ANKMY1 SFI1 WRAP53 FANCF NUP210 ELK4 NOTCH1	5.13e-05	195	152	8	6310_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	RABEP2 HIF3A SRCAP CIC MEF2D ELK1 ALK MRTFA	5.32e-05	196	152	8	2382_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A	RABEP2 SLC4A7 CUL7 WNK1 OTUD4 ELK4 ALK MRTFA	5.32e-05	196	152	8	2335_UP
Drug	6-mercaptopurine monohydrate; Down 200; 100uM; MCF7; HG-U133A	ZXDC ZNF609 STAB2 SLC4A7 GATAD2A MAST2 FANCF FLRT1	5.32e-05	196	152	8	334_DN
Drug	Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A	STAB2 NTNG1 SFI1 MAST2 HDAC7 NFATC1 SPDEF ELK4	5.32e-05	196	152	8	3122_UP
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A	ANKMY1 HIF3A SRCAP MEF2D FUT6 TRIM38 ALK MRTFA	5.32e-05	196	152	8	2390_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A	ZXDC EPPK1 PRR36 SRCAP GSK3A TBC1D9 TBC1D22A SNAPC4	5.32e-05	196	152	8	1819_DN
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	TNFRSF25 NTNG1 TMCO6 SFI1 MAP3K1 TBC1D22A SNAPC4 FUT6	5.32e-05	196	152	8	6715_UP
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	TNFRSF25 ZNF609 ABCA3 SRCAP TBC1D22A ELK1 ELK4 FUT6	5.32e-05	196	152	8	4276_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A	SFI1 HIF3A SRCAP F5 CIC TBC1D9 FUT6 ALK	5.32e-05	196	152	8	2396_DN
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	RABEP2 TNK1 ZNF280B GSK3A HROB SPDEF SEMA6A FUT6	5.52e-05	197	152	8	6203_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SLC4A7 NACA SRCAP CIC GSK3A THADA NUP210 IQSEC1	5.52e-05	197	152	8	5332_DN
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; HL60; HT_HG-U133A	RABEP2 HIF3A WRAP53 F5 IQSEC1 SEMA6A DMRT1 ALK	5.52e-05	197	152	8	2196_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A	TNFRSF25 SRCAP MAST2 WNK1 JMJD1C MEF2D HROB CUX1	5.52e-05	197	152	8	1726_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A	GATAD2A ANKMY1 WRAP53 F5 MEF2D GSK3A SNAPC4 MRTFA	5.52e-05	197	152	8	203_UP
Drug	Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A	ZXDC TMCO6 SYNPO FHOD1 NUP210 ELK1 SNAPC4 NOTCH1	5.52e-05	197	152	8	7374_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	SYNPO CUL7 WNK1 GSK3A BTN3A3 TBC1D22A FUT6 DMRT1	5.52e-05	197	152	8	3209_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A	TNFRSF25 NTNG1 SRCAP F5 ALDH1A2 FUT6 TRIM38 ALK	5.72e-05	198	152	8	6088_UP
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A	MAST2 HDAC7 GSK3A MAP3K1 NEO1 IQSEC1 SPDEF ELK4	5.72e-05	198	152	8	2170_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A	STAB2 ATG2B ANKMY1 CUL7 GSK3A HROB FUT6 MRTFA	5.72e-05	198	152	8	3676_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A	TNFRSF25 HNF1A ZNF609 STAB2 HDAC7 CIC DMRT1 MRTFA	5.72e-05	198	152	8	5006_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	SLC4A7 UNC5B SFI1 F5 CIC NFATC1 TBC1D22A CUX1	5.72e-05	198	152	8	1163_UP
Drug	BAS 012416453; Down 200; 38uM; MCF7; HT_HG-U133A	RABEP2 TGIF2 ZNF609 UNC5B ANKMY1 SFI1 SRCAP MRTFA	5.72e-05	198	152	8	6880_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A	TNFRSF25 ZNF609 ANKMY1 WRAP53 CASZ1 BTN3A3 TBC1D22A MRTFA	5.72e-05	198	152	8	4194_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	RABEP2 ZNF609 SFI1 HDAC7 ELK1 SEMA6A SNAPC4 MRTFA	5.92e-05	199	152	8	4986_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A	RABEP2 SFI1 HIF3A WRAP53 F5 MEF2D CASZ1 ALK	5.92e-05	199	152	8	2402_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; HL60; HG-U133A	TNFRSF25 ZNF609 MAST2 GSK3A PLAGL1 SNAPC4 FUT6 SEC23B	5.92e-05	199	152	8	1737_DN
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A	USP24 TMCO6 HDAC7 CASZ1 FANCF FHOD1 SNAPC4 TRIM38	6.14e-05	200	152	8	7308_DN
Drug	2-azido-ATP	WNK1 BRD2 SEMA6A	1.85e-04	17	152	3	CID000123645
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	FOXK2 SLC4A7 ZCCHC2 FHOD1 IQSEC1 ELK1 CLEC16A	2.35e-04	183	152	7	2750_DN
Drug	F0447-0125; Down 200; 10uM; PC3; HT_HG-U133A	TNFRSF25 SYNPO SFI1 WRAP53 CASZ1 GSK3A GLI2	2.43e-04	184	152	7	6429_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	RABEP2 ZXDC ZNF609 ANKMY1 SFI1 SRCAP MAP3K1	2.59e-04	186	152	7	6996_UP
Drug	5707885; Up 200; 50uM; PC3; HT_HG-U133A	SLC4A7 ANKMY1 SRCAP WNK1 HROB OTUD4 ELK1	2.59e-04	186	152	7	6438_UP
Drug	G 3012	UNC5B NTNG1 NEO1 IQSEC1 ELK1 SEMA6A	2.63e-04	132	152	6	CID000120739
Drug	NSC717830	NACA GSK3A	2.63e-04	4	152	2	CID005472313
Drug	Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A	FOXK2 NACA TBC1D22A NUP210 OTUD4 ELK4 MRTFA	2.68e-04	187	152	7	3075_DN
Drug	Digoxin [20830-75-5]; Down 200; 5.2uM; PC3; HT_HG-U133A	TNFRSF25 PIGZ HDAC7 FANCF TBC1D22A FHOD1 MRTFA	3.04e-04	191	152	7	6724_DN
Drug	PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A	RABEP2 TNFRSF25 EPPK1 SLC4A7 USP24 FHOD1 FUT6	3.04e-04	191	152	7	7086_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	TNFRSF25 SFI1 SRCAP MAST2 VAX2 FUT6 MRTFA	3.04e-04	191	152	7	3890_DN
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	SRCAP F5 HROB SPDEF VAX2 SNAPC4 ALK	3.04e-04	191	152	7	5964_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A	RABEP2 TNFRSF25 TMCO6 CUL7 HDAC7 SEMA6A ELK4	3.04e-04	191	152	7	7542_UP
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	EPPK1 GATAD2A TMCO6 SRCAP CASZ1 OTUD4 ELK4	3.04e-04	191	152	7	7435_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	STAB2 PRR36 SFI1 CUL7 TBC1D22A ALK MRTFA	3.14e-04	192	152	7	5218_UP
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	TNFRSF25 STAB2 MEF2D BTN3A3 VAX2 FUT6 MRTFA	3.24e-04	193	152	7	4743_UP
Drug	0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A	RABEP2 TNFRSF25 ANKMY1 PIGZ HROB NUP210 PLAGL2	3.34e-04	194	152	7	6895_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	EPPK1 PRR36 SRCAP TBC1D9 SPDEF FUT6 CLEC16A	3.34e-04	194	152	7	1804_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 SLC4A7 CUL7 MEF2D PLAGL1 ALK	3.34e-04	194	152	7	5418_UP
Drug	Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A	RABEP2 ZNF609 SLC4A7 SRCAP MEF2D HROB PLAGL1	3.34e-04	194	152	7	3302_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A	TANK SFI1 CASZ1 FANCF PLAGL1 SNAPC4 SEC23B	3.34e-04	194	152	7	1437_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	RABEP2 TNFRSF25 SLC4A7 UNC5B SRCAP MAP3K1 BPTF	3.34e-04	194	152	7	4391_DN
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	UNC5B SFI1 CASZ1 HROB SEMA6A ELK4 ALK	3.34e-04	194	152	7	5342_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 WNK1 VAX2 ELK1 SEMA6A ELK4	3.34e-04	194	152	7	3194_DN
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZXDC ZNF609 SYNPO WNK1 OTUD4 ELK4 NOTCH1	3.34e-04	194	152	7	4470_DN
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; HL60; HG-U133A	RABEP2 SLC4A7 UNC5B SFI1 MEF2D SNAPC4 FUT6	3.34e-04	194	152	7	1611_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A	TNFRSF25 GSK3A TBC1D9 OTUD4 ELK4 CLEC16A MRTFA	3.34e-04	194	152	7	4301_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	ZNF609 ABCA3 FOXK2 PRR36 HDAC7 CIC TRIM38	3.45e-04	195	152	7	2805_UP
Drug	Econazole nitrate [24169-02-6]; Up 200; 9uM; HL60; HT_HG-U133A	RABEP2 ZNF609 STAB2 SLC4A7 ZNF280B SFI1 MAST2	3.45e-04	195	152	7	2396_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	TNFRSF25 SRCAP GSK3A MAP3K1 FUT6 DMRT1 MRTFA	3.45e-04	195	152	7	6065_UP
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	ZXDC TNFRSF25 TANK WNK1 TBC1D9 BPTF TBC1D22A	3.45e-04	195	152	7	6643_DN
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A	ZNF609 SFI1 SRCAP F5 MEF2D MAP3K1 ELK1	3.45e-04	195	152	7	2727_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAST2 MAP3K1 TBC1D22A PLAGL2 ALK NOTCH1 MRTFA	3.45e-04	195	152	7	4358_DN
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	TNFRSF25 SRCAP MAST2 OTUD4 SNAPC4 FUT6 CLEC16A	3.45e-04	195	152	7	4019_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	SFI1 SRCAP MAST2 HDAC7 CASZ1 SPDEF FUT6	3.45e-04	195	152	7	3124_UP
Drug	Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; HL60; HG-U133A	HNF1A SLC4A7 NTNG1 ANKMY1 HDAC7 MEF2D GSK3A	3.45e-04	195	152	7	1573_UP
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 SFI1 CIC HROB TBC1D22A NUP210	3.45e-04	195	152	7	6808_UP
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	TNFRSF25 ZNF609 ABCA3 PRR36 CUL7 MEF2D HROB	3.45e-04	195	152	7	4813_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	TNFRSF25 ZNF609 SLC4A7 SRCAP NFATC1 NUP210 SNAPC4	3.45e-04	195	152	7	2071_DN
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 CUL7 SRCAP PIGZ GSK3A HROB SNAPC4	3.45e-04	195	152	7	4557_UP
Disease	triglycerides to total lipids in very large HDL percentage	JMJD1C BPTF ALDH1A2 DOCK7 FLRT1	1.63e-05	62	150	5	EFO_0022339
Disease	cholesteryl esters to total lipids in large LDL percentage	JMJD1C ALDH1A2 DOCK7 NLRC5	1.81e-05	31	150	4	EFO_0022249
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HNF1A GATAD2A USP24 JMJD1C BPTF ALDH1A2 DOCK7 NLRC5 SPDEF	1.92e-05	291	150	9	EFO_0008317, EFO_0020946
Disease	lymphocyte measurement	DLEU1 JMJD1C ANAPC1 NUP210 IQSEC1 NLRC5	3.07e-05	117	150	6	EFO_0803546
Disease	neutrophil percentage of leukocytes	HNF1A SFI1 HDAC7 JMJD1C THADA NFATC1 NLRC5 PLAGL1 SNAPC4 BCL2L13 CLEC16A MRTFA	7.09e-05	610	150	12	EFO_0007990
Disease	inflammatory bowel disease	HIF3A F5 HDAC7 KPNA7 THADA BRD2 NFATC1 SPDEF BSN NOTCH1	1.06e-04	449	150	10	EFO_0003767
Disease	cholesteryl esters to total lipids in small VLDL percentage	JMJD1C ALDH1A2 DOCK7 NLRC5	1.14e-04	49	150	4	EFO_0022256
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	HIF3A HDAC7 KPNA7 THADA NFATC1 BSN CLEC16A NOTCH1	1.40e-04	295	150	8	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	phospholipids:total lipids ratio	HNF1A USP24 JMJD1C BPTF ALDH1A2 DOCK7 NLRC5	1.69e-04	227	150	7	EFO_0020946
Disease	sexual dimorphism measurement	HNF1A EPPK1 DLEU1 ZC3H11B ISLR JMJD1C BPTF HROB ALDH1A2 GLI2 FER1L4 OTUD4 NLRC5 SPDEF BSN SPOCD1	1.69e-04	1106	150	16	EFO_0021796
Disease	diastolic blood pressure, systolic blood pressure	SLC4A7 GATAD2A HCN1 DNAH2 ZC3H11B RBBP8NL KCNK9 CASZ1 PIEZO2 VWA3B CLEC16A CUX1	1.70e-04	670	150	12	EFO_0006335, EFO_0006336
Disease	breast carcinoma	FOXK2 SLC4A7 GATAD2A L3MBTL2 HCN1 DLEU1 MAST2 JMJD1C CASZ1 MAP3K1 ZC3H11A GLI2 MAST1 CUX1 MRTFA	2.26e-04	1019	150	15	EFO_0000305
Disease	total lipids in IDL	HNF1A JMJD1C ALDH1A2 DOCK7	2.51e-04	60	150	4	EFO_0022161
Disease	triglyceride measurement, intermediate density lipoprotein measurement	HNF1A GPR146 BPTF ALDH1A2 DOCK7	2.64e-04	111	150	5	EFO_0004530, EFO_0008595
Disease	triglycerides in small VLDL measurement	JMJD1C BPTF ALDH1A2 DOCK7	2.67e-04	61	150	4	EFO_0022145
Disease	testosterone measurement	HNF1A DLEU1 DNAH2 NTNG1 ZC3H11B WRAP53 SRCAP JMJD1C THADA LIPE NFATC1 ANAPC1 PLAGL1 SPOCD1 MUCL3 TRIM38 ARHGAP21	2.75e-04	1275	150	17	EFO_0004908
Disease	triglycerides in small HDL measurement	JMJD1C BPTF ALDH1A2 DOCK7	2.85e-04	62	150	4	EFO_0022158
Disease	inflammatory biomarker measurement	F5 JMJD1C PIEZO2	3.07e-04	26	150	3	EFO_0004872
Disease	adult onset asthma	HDAC7 BRD2 PLAGL1 UHRF2 CLEC16A	3.50e-04	118	150	5	EFO_1002011
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 WNK2	3.80e-04	6	150	2	DOID:4479 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (18:2_18:2) in blood serum	ALDH1A2 DOCK7	3.80e-04	6	150	2	OBA_2045106
Disease	Tumor of Rete Testis	ATF7IP DMRT1	3.80e-04	6	150	2	C1720811
Disease	monocyte count	STAB2 DLEU1 MAST2 WNK1 TMEM87A CIC MEF2D CASZ1 GSK3A THADA BRD2 NLRC5 MAST1 SPDEF PLAGL1 BCL2L13 MRTFA	4.09e-04	1320	150	17	EFO_0005091
Disease	resistin measurement	LHX8 THADA PLAGL1	4.27e-04	29	150	3	EFO_0004819
Disease	eosinophil percentage of leukocytes	DLEU1 HIF3A WNK1 JMJD1C BPTF THADA ANAPC1 NLRC5 UNK UHRF2 CLEC16A CUX1	4.49e-04	746	150	12	EFO_0007991
Disease	lymphocyte count	EPPK1 SLC4A7 DLEU1 SFI1 HIF3A HDAC7 JMJD1C CASZ1 THADA ALDH1A2 BRD2 NFATC1 ANAPC1 NLRC5 ELK4 CLEC16A MUCL3 MRTFA	4.76e-04	1464	150	18	EFO_0004587
Disease	triglycerides to total lipids in small HDL percentage	JMJD1C ALDH1A2 DOCK7 NLRC5	5.05e-04	72	150	4	EFO_0022336
Disease	serum alanine aminotransferase measurement	HNF1A DLEU1 DNAH2 NTNG1 ZC3H11B MEF2D MAP3K1 BPTF ALDH1A2 NUP210 UNK BCL2L13 WNK2	5.16e-04	869	150	13	EFO_0004735
Disease	cholesterol to total lipids in very large HDL percentage	HNF1A ALDH1A2 DOCK7	5.21e-04	31	150	3	EFO_0022243
Disease	Malignant neoplasm of testis	ATF7IP DMRT1	5.30e-04	7	150	2	C0153594
Disease	Swyer Syndrome	MAP3K1 DMRT1	5.30e-04	7	150	2	C2936694
Disease	pentachlorophenol measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022071
Disease	parathion measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022070
Disease	potassium chromate measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022072
Disease	mercuric chloride measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022068
Disease	heptachlor epoxide measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022067
Disease	methoxychlor measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022052
Disease	azinphos methyl measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022055
Disease	aldrin measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022054
Disease	dicofol measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022060
Disease	disulfoton measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022062
Disease	dieldrin measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022061
Disease	endrin measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022064
Disease	endosulfan measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022063
Disease	heptachlor measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022066
Disease	ethion measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022065
Disease	chlorpyrifos measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022057
Disease	cadmium chloride measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022056
Disease	diazinon measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022059
Disease	dibutyl phthalate measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0022058
Disease	environmental exposure measurement	NTNG1 MUC16 RBBP8NL F5	5.32e-04	73	150	4	EFO_0008360
Disease	free cholesterol to total lipids in large LDL percentage	JMJD1C ALDH1A2 DOCK7 FLRT1	5.60e-04	74	150	4	EFO_0022280
Disease	DDT metabolite measurement	NTNG1 MUC16 RBBP8NL F5	5.60e-04	74	150	4	EFO_0007886
Disease	eosinophil count	DLEU1 WNK1 BPTF KPNA7 FNDC1 THADA ALDH1A2 ANAPC1 ATF7IP NLRC5 UNK PLAGL1 VWA3B UHRF2 BCL2L13 CLEC16A NOTCH1 CUX1	5.76e-04	1488	150	18	EFO_0004842
Disease	stem Cell Growth Factor beta measurement	OMA1 STAB2 F5 PIEZO2	5.89e-04	75	150	4	EFO_0008292
Disease	intellectual disability (implicated_via_orthology)	GATAD2A ZNF280B MEF2D ATF7IP	5.89e-04	75	150	4	DOID:1059 (implicated_via_orthology)
Disease	lymphocyte percentage of leukocytes	HNF1A DLEU1 HDAC7 JMJD1C THADA NFATC1 NLRC5 PLAGL1 SNAPC4 BCL2L13 MRTFA	6.19e-04	665	150	11	EFO_0007993
Disease	C-reactive protein measurement, high density lipoprotein cholesterol measurement	HNF1A JMJD1C ALDH1A2	6.86e-04	34	150	3	EFO_0004458, EFO_0004612
Disease	triglyceride measurement, physical activity	JMJD1C ALDH1A2 DOCK7	6.86e-04	34	150	3	EFO_0003940, EFO_0004530
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	HNF1A USP24 JMJD1C ALDH1A2 DMRT1	6.92e-04	137	150	5	EFO_0004611, EFO_0008591
Disease	Gonadal Dysgenesis, 46,XY	MAP3K1 DMRT1	7.04e-04	8	150	2	C0018054
Disease	Testicular Neoplasms	ATF7IP DMRT1	7.04e-04	8	150	2	C0039590
Disease	central serous retinopathy	RBBP8NL WNK1	7.04e-04	8	150	2	EFO_0009784
Disease	level of Phosphatidylcholine (18:1_18:1) in blood serum	ALDH1A2 DOCK7	7.04e-04	8	150	2	OBA_2045099
Disease	citrate measurement	JMJD1C NFATC1 ALK WNK2	7.17e-04	79	150	4	EFO_0010114
Disease	Spinocerebellar Ataxia Type 4	PLEKHG4 CIC VWA3B	7.48e-04	35	150	3	C0752122
Disease	free cholesterol in small HDL measurement	ALDH1A2 DOCK7 NLRC5	7.48e-04	35	150	3	EFO_0022270
Disease	cholesteryl esters to total lipids in very large HDL percentage	ALDH1A2 DOCK7 NLRC5	8.13e-04	36	150	3	EFO_0022257
Disease	serum gamma-glutamyl transferase measurement	HNF1A ARPP21 NTNG1 ZC3H11B FBXL19 JMJD1C BPTF THADA ALDH1A2 GYS2 FLRT1 FUT6 ARHGAP21	8.22e-04	914	150	13	EFO_0004532
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	HNF1A GATAD2A JMJD1C ALDH1A2 DOCK7	8.66e-04	144	150	5	EFO_0004611, EFO_0020943
Disease	white matter microstructure measurement	EPPK1 TMCO6 MAST2 BPTF ALDH1A2 NFATC1 UNK ARHGAP21	8.94e-04	390	150	8	EFO_0005674
Disease	adiponectin measurement	DLEU1 ZC3H11B KCNK9 LINC00528 VWA3B	9.22e-04	146	150	5	EFO_0004502
Disease	reticulocyte count	FOXK2 GATAD2A DLEU1 ZC3H11B MAST2 JMJD1C MAP3K1 THADA OTUD4 MAST1 FLRT1 BSN SPOCD1 CUX1	9.25e-04	1045	150	14	EFO_0007986
Disease	intermediate density lipoprotein measurement	HNF1A JMJD1C ALDH1A2 DOCK7	1.03e-03	87	150	4	EFO_0008595
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	HNF1A USP24 JMJD1C ALDH1A2 NLRC5 SPDEF	1.06e-03	225	150	6	EFO_0008317, EFO_0020947
Disease	cholesterol in very small VLDL measurement	HNF1A ALDH1A2 DOCK7	1.11e-03	40	150	3	EFO_0022231
Disease	ankyrin-2 measurement	OPTC ZC3H11A	1.12e-03	10	150	2	EFO_0021874
Disease	coronary artery disease	OMA1 HNF1A HCN1 MAP3K1 KIAA0319 FNDC1 THADA ZC3H11A ALDH1A2 NUP210 BSN ALK ARHGAP21 WNK2 MRTFA	1.16e-03	1194	150	15	EFO_0001645
Disease	Malignant neoplasm of breast	ABCA3 TANK WNK1 HDAC7 CIC MAP3K1 ZC3H11A KMT2D LIPE NLRC5 SPOCD1 ALK NOTCH1 CUX1	1.20e-03	1074	150	14	C0006142
Disease	C-reactive protein measurement	HNF1A ARPP21 HIF3A ZCCHC2 MAP3K1 BPTF NEO1 ALDH1A2 GYS2 DOCK7 SNAPC4 BSN BCL2L13 ARHGAP21 CUX1	1.28e-03	1206	150	15	EFO_0004458
Disease	schizophrenia, type 2 diabetes mellitus	HNF1A GATAD2A HCN1	1.37e-03	43	150	3	MONDO_0005090, MONDO_0005148
Disease	cholesteryl esters to total lipids in small HDL percentage	HNF1A ALDH1A2 DOCK7	1.37e-03	43	150	3	EFO_0022254
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	HNF1A JMJD1C ALDH1A2 DOCK7	1.37e-03	94	150	4	EFO_0008595, EFO_0010351
Disease	obsolete_red blood cell distribution width	TNFRSF25 HNF1A FOXK2 GATAD2A L3MBTL2 ZCCHC2 WNK1 MAP3K1 NEO1 ZC3H11A NUP210 MAST1 TRIM38 ARHGAP21 NOTCH1 SEC23B	1.42e-03	1347	150	16	EFO_0005192
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HNF1A JMJD1C ALDH1A2 DOCK7 NLRC5 SPDEF	1.44e-03	239	150	6	EFO_0008317, EFO_0020945
Disease	lipid measurement, intermediate density lipoprotein measurement	HNF1A JMJD1C ALDH1A2 DOCK7	1.48e-03	96	150	4	EFO_0004529, EFO_0008595
Disease	total lipids in very small VLDL measurement	HNF1A ALDH1A2 DOCK7	1.56e-03	45	150	3	EFO_0022156
Disease	saturated fatty acids measurement	HNF1A ALDH1A2 DOCK7	1.56e-03	45	150	3	EFO_0022304
Disease	cholesterol to total lipids in large VLDL percentage	JMJD1C ALDH1A2 NLRC5	1.56e-03	45	150	3	EFO_0022236
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	HNF1A JMJD1C BPTF ALDH1A2 DOCK7 NLRC5	1.56e-03	243	150	6	EFO_0004612, EFO_0020944
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	HNF1A GPR146 BPTF ALDH1A2 DOCK7	1.63e-03	166	150	5	EFO_0004530, EFO_0004611
Disease	diabetic maculopathy	DLEU1 ALK	1.64e-03	12	150	2	EFO_0010133
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	ALDH1A2 DOCK7	1.64e-03	12	150	2	OBA_2045157
Disease	ulcerative colitis	HDAC7 KPNA7 BRD2 NUP210 SNAPC4 BSN NOTCH1	1.68e-03	335	150	7	EFO_0000729
Disease	free cholesterol in very small VLDL measurement	HNF1A ALDH1A2 DOCK7	1.77e-03	47	150	3	EFO_0022275
Disease	blood cobalt measurement	NTNG1 MUC16 RBBP8NL F5	1.79e-03	101	150	4	EFO_0007577
Disease	total lipids in lipoprotein particles measurement	HNF1A ALDH1A2 DOCK7	1.88e-03	48	150	3	EFO_0022309
Disease	phosphoglycerides measurement	HNF1A ALDH1A2 DOCK7	1.88e-03	48	150	3	EFO_0022291

Protein segments in the cluster

Peptide	Gene	Start	Entry
LPSPLITFTDSLHHP	ZNF280B	141	Q86YH2
APAPLLPHITATSLL	BCL2L13	341	Q9BXK5
LPHITATSLLGTREP	BCL2L13	346	Q9BXK5
ALTPSLLPTHTLTPV	ELK1	351	P19419
LLPTHTLTPVLLTPS	ELK1	356	P19419
HTPINGSLPSLLLSP	ARHGEF25	516	Q86VW2
LVPDHSLETPLTPGL	BTN3A3	526	O00478
HLISLEVSPPPTLSQ	ADGRD1	461	Q6QNK2
VPHLPASPLATTSLE	CASZ1	1136	Q86V15
ASLHLLPSPTPNLEI	ALDH1A2	21	O94788
QPTTPLPLSGHSALS	CUX1	1101	P39880
ILHPEFLSSTSPLLP	GYS2	476	P54840
VLSHPSPPEGLSFSL	LINC00528	101	Q8N1L1
TRILAPSPDSLLHTP	ABCA3	1366	Q99758
SSASGPLHSVSLPLP	AMOTL1	396	Q8IY63
PPAVQHTGLLSTPTL	BPTF	2816	Q12830
SLSRTHPPLQSTPLV	ARPP21	421	Q9UBL0
ISVLHIDPLSPPETS	ATG2B	516	Q96BY7
LHGPLTLNSPLTPEK	AOX1	1296	Q06278
GDPSVHLLTAPTSPL	FBXL19	611	Q6PCT2
HVSLSNPAPLLVSPE	OTUD4	566	Q01804
LVSPEVHLTPAVPSL	OTUD4	576	Q01804
HGSTELLPLSRDPSP	RABEP2	191	Q9H5N1
TLVLPLVPELLSTHP	INTS4	516	Q96HW7
LFPSPISSISPGLHS	KCNK9	346	Q9NPC2
HIPALLPPTSTELDV	ANAPC1	1231	Q9H1A4
SIRQHSSTGPPPLLL	GATAD2A	256	Q86YP4
PHDPLVPLSASIELI	NUP210	876	Q8TEM1
SPHPVTALLTLGPVK	MUC16	8586	Q8WXI7
SILTLDSLTPHPGLP	PLAC4	111	Q8WY50
SVLSLLGLPTPGPSH	MBD6	411	Q96DN6
PHLLALISPTLPITF	KPNA7	201	A9QM74
LAVHTILPQESPALP	NOTCH1	2451	P46531
PAGLLTLVTSRHPAL	FANCF	256	Q9NPI8
LPSSHLRPITDSPVL	MAT2B	271	Q9NZL9
LLPISAHPNATPALS	MUC15	131	Q8N387
TSPLHLLSPGTPRSL	L3MBTL2	66	Q969R5
AHLISPLPSPTGTIS	FOXK2	191	Q01167
HLPLLTIEPPSDSSV	IQSEC1	376	Q6DN90
PALTPAPHLLAGSSS	JMJD1C	756	Q15652
LLPEPSAGLPSSLHR	FER1L4	741	A9Z1Z3
SHLSLGTTLPVILPE	DLEU1	31	O43261
SPVSPLSPHRLLDTS	BSN	2796	Q9UPA5
PSSPSVSSLLLHLRP	C9orf131	276	Q5VYM1
TSPHVLKGTPLSRLP	ISLR	211	O14498
SIPGPLPLSLRSVHL	OPTC	261	Q9UBM4
TIPPAPLLHTVHVLS	CUL7	131	Q14999
LCETSTPLHPQLLPL	INTS2	581	Q9H0H0
NVSPALPLPTAHSTL	NFATC1	51	O95644
SLHLPTNPTSLPAVA	PRCP	31	P42785
PLPPVSTLTALHSLE	HNF1A	376	P20823
DAHSPTTLGLQPLLP	LHX8	331	Q68G74
LLLHPTAPSEALGLP	HROB	61	Q8N3J3
SDISLIRLSPHPAGP	GLI2	96	P10070
LSPPGHLPTSSLLDL	NLRC5	446	Q86WI3
SLILTSTSPTLPRPH	MAST1	36	Q9Y2H9
ASLPAIGTIRPPHSL	OLIG3	201	Q7RTU3
IGTIRPPHSLLKAPS	OLIG3	206	Q7RTU3
LPSQDPHLPLASLVS	PCDHB12	491	Q9Y5F1
LPSQDPHLPLASLVS	PCDHB7	491	Q9Y5E2
LSLHLQSPHSSPLAP	RBBP8NL	296	Q8NC74
LGPPRTDCLTLLHTP	ASPHD2	6	Q6ICH7
PSLPHEVSTLISRPH	HCN1	791	O60741
IPPHLRSPAGTTTLT	GSK3A	441	P49840
GLLRPHVPPAAITTL	DOCK7	311	Q96N67
LGILSPSLPTASLTP	ELK4	341	P28324
TPIILTPSPLLSSIH	ELK4	361	P28324
VLPTTSLGHPSLSAP	CRTC2	381	Q53ET0
SSRLLPTQPHLSSPL	FNDC1	726	Q4ZHG4
TSPEPLPTNHPLLTL	GRHPR	271	Q9UBQ7
VSVSHFLPLPPSLSH	CARD19	171	Q96LW7
FPPQLSTLTPLHIAA	ANKMY1	576	Q9P2S6
PDSTGTPAHSIPLIL	FUT6	51	P51993
GPSQTTIHLLPTAPT	ATF7IP	1021	Q6VMQ6
LIVTSSTSPTLPRPH	MAST2	176	Q6P0Q8
NDPPDHPILSSLSIL	SLC44A3	416	Q8N4M1
LSSIPSGLPHTLEEL	FLRT1	161	Q9NZU1
LLDPSGSHAPLLTVP	HDAC7	311	Q8WUI4
LAAPLPHSVPDSSAL	FHOD1	606	Q9Y613
LSALAPVHLLGPPSS	GPR146	76	Q96CH1
SCVVPSLSLLHHPLP	GPR21	81	Q99679
SLPLVPQHSFASLPL	CEP295	1396	Q9C0D2
LSSIPHPDFPISILQ	DNAH2	3926	Q9P225
LGISHPIPLPSAAEL	DMRT1	131	Q9Y5R6
ADPTLTVTISPPLAH	LIPE	581	Q05469
HLVPVSLSNLIPGSP	MEF2D	406	Q14814
LSTSDHIFPLTPGLV	MUCL3	41	Q3MIW9
TTLTPLQHLPPLAAV	ONECUT3	106	O60422
LAIPHTPESSSLPVA	OTOG	1571	Q6ZRI0
LTPATSHPLTPLVAE	OTOG	1946	Q6ZRI0
PTDISSLPTPIHIIS	MUC3B	426	Q9H195
SLPTPIHIISSSPSI	MUC3B	431	Q9H195
PSIPSHLSPGLRDVA	MAP3K1	1471	Q13233
APPHGSPALLLLTTL	NTNG1	516	Q9Y2I2
SSLASVPDPHLLLPG	SFI1	1116	A8K8P3
LTSPPTSLHLHEQPL	TRIM38	396	O00635
LTSTTPLFLTNPHPI	THADA	1706	Q6YHU6
QPLPESLASLHPSVS	PLAGL1	276	Q9UM63
LISSDPFLIHPPHLS	RNF38	266	Q9H0F5
SPLSLLLGHLLPSSR	SLC4A7	276	Q9Y6M7
GVSLHPSLPLLATAS	WRAP53	466	Q9BUR4
LTPGLSPQPALHALS	PRSS29P	21	A6NIE9
LKPLLTHSGPPLTTT	SLC9A6	546	Q92581
TASLPDLPSLHTFLP	SYNE3	466	Q6ZMZ3
PLSPDPSHTTLSLDL	F5	1356	P12259
LLTHIPTAGLPTSLG	PLEKHG4	306	Q58EX7
HAPGLSLSSTSLPEP	SYNPO	211	Q8N3V7
SFHGLSPPALEPSLL	HIF3A	526	Q9Y2N7
PSLQATPHTLATLPL	PRR36	506	Q9H6K5
TPHTLATLPLQDSPL	PRR36	511	Q9H6K5
VSPLSSPLTIHPLQA	PRR36	676	Q9H6K5
ETSGLHLLPLPESAP	EPPK1	1106	P58107
IILEHAPATTGPLPS	NEO1	426	Q92859
LHSTPERPGILSPAT	TANK	246	Q92844
SAHEAPGPAPSLLLL	SWSAP1	81	Q6NVH7
GAAPLTISSPLHVPS	SRCAP	1391	Q6ZRS2
SSSQTPGHPLLLAPT	SRCAP	1516	Q6ZRS2
LEHPLQPLFGTPTSL	MRTFA	706	Q969V6
VPSLSVLHPLSPASI	OMA1	116	Q96E52
PLHSLPPVFTSGLSS	PLAGL2	471	Q9UPG8
HGPPEPVLLDSSSIL	SEC23B	631	Q15437
LSHSQSLSSHLLPPP	STARD3	26	Q14849
SLPLLHTPIPLVSEN	TGIF2	221	Q9GZN2
PHPSVISSPLLKSLH	BRD2	241	P25440
ISSPLLKSLHSAGPP	BRD2	246	P25440
TPEPHLPLSLILSVV	ALK	1026	Q9UM73
AATSPAPHLVAGPLL	CIC	736	Q96RK0
SLTLVPPVDPHSLRS	CLEC16A	1006	Q2KHT3
PSTFLPHSSTPALHL	ZCCHC2	796	Q9C0B9
LLVRPDPDHLPGTST	UHRF2	71	Q96PU4
ISFSTLTPTIIPAHP	ZNF804B	1246	A4D1E1
LTPTIIPAHPTFLAG	ZNF804B	1251	A4D1E1
HSDIPPSLDSPLVLG	ZXDC	571	Q2QGD7
PSSVADGLPLLHLSP	UNC80	2651	Q8N2C7
TPLCPSHSSLHPVLL	RNPC3	291	Q96LT9
VSPSHLLLPPDTVSR	SPDEF	11	O95238
TDLPLRASPSHIPSV	SEMA6A	801	Q9H2E6
PLLSPGLEVTHSSLL	SPOCD1	996	Q6ZMY3
SSGVSSLLLHPEPVP	ZC3H11A	236	O75152
STLPPIPHLHSLLSD	TBC1D9	746	Q6ZT07
SLPLSHAVIPTQLPS	ZNRF4	21	Q8WWF5
LGSSILPPLTHELTA	PIEZO2	1866	Q9H5I5
ESPVSTPAVLPIHLL	ZNF609	251	O15014
PGPLLPALLHTLAFS	TMCO6	421	Q96DC7
LKAPPAPVTLTHTGL	STAB2	2446	Q8WWQ8
PHLTLEDPPALSSLL	PIGZ	546	Q86VD9
LLHPSVPPDLTASAG	UNC5B	436	Q8IZJ1
PPFDPLLHGTLLRST	TBC1D22A	31	Q8WUA7
HLSPLDSAHTLLAPP	TNFRSF25	251	Q93038
SSGVSSLLLHPEPVP	ZC3H11B	236	A0A1B0GTU1
VPSLTFPHAVLIPTS	ZNF621	381	Q6ZSS3
SIAPSSPLLPLHEEV	USP24	2371	Q9UPU5
LGSLHARLTAPAPTP	TNK1	201	Q13470
LALTPSLPGLPASHR	VAX2	201	Q9UIW0
LLVSSSVILQPPLPH	SNAPC4	921	Q5SXM2
RLGLSSHAIIATPPP	VWA3B	1256	Q502W6
GLHPLVIPSVIASTP	WNK1	1566	Q9H4A3
QHLLPPTLPTSATSL	WNK2	596	Q9Y3S1
PHVLCSTLSLSRPSP	nan	181	Q8N1Y9
PHLTPEITPLSAALA	ZC3H10	356	Q96K80
VSPSSPHAPDLSALL	UNK	356	Q9C0B0
RTTSPPLSIPTTHLI	ARHGAP21	316	Q5T5U3
PSVIILLSLFSTPHG	UPRT	261	Q96BW1
PVILLLLGAHPSPLS	TMEM87A	11	Q8NBN3
PSHPSVLSLSTAPLV	UNC79	1671	Q9P2D8
VKSLDLLAALPTPPH	KMT2D	4671	O14686
PSHSLPPASLELSSV	KIAA0319	271	Q5VV43
PSSSAPLALVALAPH	NACA	131	E9PAV3